rheumatoid arthritis

Zalicus Is Locked And Loaded: What You Need To Know
Seeking Alpha
Thu, 05/24/12 - 10:14 am
Zalicus
Synavive
rheumatoid arthritis
A $4 Biotech Play Insiders Are Buying Hand Over Fist
Seeking Alpha
Sun, 05/13/12 - 01:03 pm
Horizon Pharma
Duexis
arthritis
rheumatoid arthritis
osteoarthritis
Lodotra
Pfizer: Is 8 Really Enough?
Seeking Alpha
Sat, 05/12/12 - 11:26 am
Pfizer
tofacitinib
rheumatoid arthritis
FDA panel favors novel arthritis drug from Pfizer
Yahoo/AP
Thu, 05/10/12 - 10:57 am
FDA
advisory panels
Pfizer
rheumatoid arthritis
tofacitinib
Pfizer's Must-Win FDA Vote
Motley Fool
Tue, 05/8/12 - 07:18 pm
FDA
Pfizer
rheumatoid arthritis
tofacitinib
Amgen
JNJ
Merck
Abbott Laboratories
Pfizer Arthritis Pill Raises Safety Concerns, FDA Staff Says
Bloomberg
Mon, 05/7/12 - 11:12 am
Pfizer
tofacitinib
rheumatoid arthritis
FDA
Preview: U.S. panel seen backing Pfizer's arthritis drug hope
Reuters
Fri, 05/4/12 - 10:49 am
FDA
advisory panels
Pfizer
tofacitinib
rheumatoid arthritis
2 Attractive Biotech Stocks, With Good Entry Points
Seeking Alpha
Sat, 04/14/12 - 12:21 pm
Horizon Pharma
Duexis
Lodotra
arthritis
rheumatoid arthritis
pain management
Pfizer’s Rheumatoid Arthritis Pill: Not A Slam Dunk
Pharmalot
Tue, 03/20/12 - 10:17 am
Pfizer
rheumatoid arthritis
tofacitinib
Roche Scores Important Win With Actemra
Seeking Alpha
Sun, 03/4/12 - 12:12 pm
Roche
Actemra
arthritis
rheumatoid arthritis
FDA accepts application for Pfizer arthritis drug
Yahoo/AP
Tue, 12/20/11 - 07:49 pm
Pfizer
FDA
rheumatoid arthritis
tofacitinib
The Sun May Not Rise At Horizon Pharma For Duexis
Seeking Alpha
Mon, 12/19/11 - 08:20 am
rheumatoid arthritis
osteoarthritis
Horizon Pharma
Duexis
FDA accepts Horizon Pharma's Lodotra application
Yahoo/AP
Tue, 11/29/11 - 09:32 am
FDA
Horizon Phamra
Lodotra
rheumatoid arthritis
New Patent Could Be Worth $6 A Share To Amgen
Forbes
Mon, 11/28/11 - 09:55 am
Amgen
patents
Enbrel
rheumatoid arthritis
Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:45 pm
Abbott Laboratories
Humira
rheumatoid arthritis
Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With Moderately Active Disease
Yahoo/PR NewsWire
Sun, 11/6/11 - 12:01 pm
Enbrel
Amgen
rheumatoid arthritis
Phase 2 Data for Selective Oral JAK3 Inhibitor VX-509 Show Significant Improvements in Signs and Symptoms of Rheumatoid Arthritis
Yahoo/BusinessWire
Sun, 11/6/11 - 11:59 am
Vertex Pharmaceuticals
JAK3 inhibitors
VX-509
rheumatoid arthritis
Pfizer’s Arthritis Pill Matches Abbott’s Shot in Studies
Bloomberg
Thu, 09/8/11 - 12:52 pm
Pfizer
Abbott Laboratories
tofacitinib
rheumatoid arthritis
Vertex Arthritis Pill Shines in Mid-Stage Study
TheStreet.com
Tue, 09/6/11 - 12:10 pm
Vertex
rheumatoid arthritis
VX-509
U.S. Food and Drug Administration Approves Subcutaneous Formulation of ORENCIA® (abatacept), a Proven Non-Anti-TNF Biologic for Adults with Moderate to Severe Rheumatoid Arthritis
Yahoo/BusinessWire
Sat, 07/30/11 - 10:40 am
Orencia
rheumatoid arthritis
Bristol-Myers Squibb

Pages